JOBST® - Preparing for the Lymphedema Treatment Act

Jobst USA>Patients>News and Events>JOBST® - Preparing for the Lymphedema Treatment Act

What is the Lymphedema Treatment Act?

The Lymphedema Treatment Act (LTA) is a federal law passed on 12/23/22 that went into effect on 1/1/24 to improve insurance coverage for the medically necessary, doctor-prescribed compression supplies that are the cornerstone of lymphedema treatment. Although this bill will only change Medicare law, it will set a standard for Medicaid and private insurance to follow.

JOBST offers a wide assortment of compression products in a number of categories outlined by theLymphedema Treatment Act.

We have created a permanent resource to navigating the Lymphedema Treatment Act on our educational platform, JOBST Compression Institute. This site will be kept up-to-date with the latest resources from JOBST as we continue our journey towards understanding this law and its impacts. We invite you to bookmark this page and check back regularly for updated resources.

VISIT JCI

 

 

Please note: A HCPCS Code (Healthcare Common Procedure Coding System Codes) is never a guarantee of coverage or payment for any claim submitted for payment to any private and public insurance carrier. If you need further information reach out to your JOBST sales representative or visit www.cms.gov/medicare/payment/fee-schedules/dmepos-fee-schedule/lymphedema-compression-treatment-items. The BSN Medical, Inc. Reimbursement Disclaimer:The Centers for Medicare & Medicaid Services (CMS) uses Palmetto GBA as the Pricing, Data Analysis, and Coding (PDAC) Contractor. The PDAC Contractor maintains the Product Classification List, located at www4.palmettogba. com/pdac.dmecs/. The Product Classification List is a searchable database containing products that have received HCPCS coding verification from PDAC and their corresponding HCPCS codes. BSN Medical Inc., however, makes no representations as to the accuracy of the information contained within the PDAC database, nor any representations as to whether its products are reimbursable under any government sponsored healthcare program and/or private-insurance program. It is the provider’s sole responsibility, in consultation with the insurer, if necessary, to determine medical necessity, ensure coverage criteria is met, and submit appropriate codes, modifiers, and charges for services rendered. RV: 12/23